CompletedEarly Phase 1NCT04267874
Official study title

Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

Study summary

This trial studies how well black raspberry nectar works in changing the gut microbiome and in reducing inflammatory processes that may lead to lung cancer. Studying the effects of black raspberry beverage on inflammation may help doctors find strategies to reduce the risk of developing lung cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalPrevention

This describes the study’s primary purpose.

What is being studiedBiospecimen Collection and Nutritional Supplementation

Plus 2 other study approaches.

Who it may be forLung Carcinoma · Tobacco-Related Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Dec 1, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Early Phase 1

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Ohio State University Comprehensive Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Early Phase 1
Sponsor
Ohio State University Comprehensive Cancer Center
Interventions being studied
Procedure: Biospecimen Collection; Dietary Supplement: Nutritional Supplementation; Drug: Placebo Administration; Other: Questionnaire Administration
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Have a 30 pack-year smoking history
  • Be either a current smoker or a former smoker that quit in the last 15 years. Any individual who is currently smoking and has smoked more than 100 cigarettes in their lifetime will be identified as a current smoker
  • Agree to consume a standardized vitamin / mineral supplement and avoid other nutritional, dietary or alternative medications / supplements / probiotics for the duration of the study
  • Agree to follow a berry-free / controlled phenolic diet and to document consumption of polyphenolic foods each day of the study using a simple daily form
Reasons someone may not be able to joinExclusion criteria
  • Person has an allergy to any berries, pectin, or food colorants apples,as well as kiwi fruit, strawberries, soy sauce, pine nuts, almonds, cherries, peaches, blackberries, pears
  • Person states that they are not a:
  • Current smoker: active cigarette smoker who has smoked more than 30 pack-years in the last 15 years OR
  • Former smoker: not a current smoker active cigarette smoker who has smoked more than 30 pack years in the last 15 years
  • Person is unwilling to follow a berry-free/controlled polyphenol diet while on study
  • Person has history of metabolic disorders (diabetes, hyper/hypo-thyroidism, etc.); digestive illness which may result in nutrient malabsorption (Crohn's disease, Celiac, renal/hepatic insufficiency, short bowel, etc.); disorders that affect connective tissues; or blood clotting disorders
  • Person has allergy or food intolerance to ingredients in study products (black raspberries or other berries)
  • Person is on a regimen of any of the following medications:
  • Immunosuppressants, bisphosphonates, or steroids.
  • Anticoagulants (warfarin, apixaban, dabigatran, and rivaroxaban)
  • Probiotics
  • Person is undergoing treatment for cancer in any form
  • Person is currently pregnant or nursing or plans to become pregnant during this study
  • Person plans to enter smoking cessation or change their smoking status during the course of the study

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Ohio State University Comprehensive Cancer CenterColumbus, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 1, 2023. Always confirm current availability with the study team.

View original record ↗